Source: VAERS.HHS.GOV
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Key considerations and limitations of VAERS data:
VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.
Asthenia; General malaise; Pallor; Feeling of heat; Blurred vision; Lipothymia; Faintness; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Physician) from the Regulatory authority -WEB. Regulatory number: FR-AFSSAPS-AM20220374. A 10 year-old male patient received bnt162b2 (COMIRNATY), intramuscular, administration date 09Jan2022 16:20 (Lot number: FN4072) at the age of 10 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Asthenia"; MALAISE (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "General malaise"; PALLOR (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Pallor"; FEELING HOT (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Feeling of heat"; VISION BLURRED (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Blurred vision"; PRESYNCOPE (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Lipothymia"; DIZZINESS (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Faintness"; FATIGUE (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Fatigue". There was no loss of urine, he had eaten well for lunch. Kept at the vaccination center with infusion and given sugar but persistence of significant asthenia with impossibility to stand up. The patient was hospitalized for asthenia, malaise, pallor, feeling hot, vision blurred, presyncope, dizziness, fatigue (Hospitalized for monitoring with favorable evolution and discharge authorized the next morning. Hospitalization duration: 1 day(s)). The patient underwent the following laboratory tests and procedures: blood glucose: normal; blood pressure measurement: normal; electrocardiogram: normal; heart rate: normal; oxygen saturation: 100 %. Therapeutic measures were taken as a result of asthenia, malaise, pallor, feeling hot, vision blurred, presyncope, dizziness, fatigue. No follow-up attempts are possible. No further information is expected.
| Vaccine Type | Manufacturer | Vaccine Name | Dose | Route | Site | Lot |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| RECVDATE: | 03 March 2022 |
| CAGE_YR: | |
| CAGE_MO: | |
| RPT_DATE: | |
| DIED: | |
| DATEDIED: | |
| L_THREAT: | |
| ER_VISIT: | |
| HOSPITAL: | Y |
| HOSPDAYS: | 1 |
| X_STAY: | |
| DISABLE: | |
| RECOVD: | Y |
| LAB_DATA: | Test Name: blood glucose; Result Unstructured Data: Test Result:normal; Test Name: blood pressure; Result Unstructured Data: Test Result:normal; Test Name: ECG; Result Unstructured Data: Test Result:normal; Test Name: heart rate; Result Unstructured Data: Test Result:normal; Test Name: SpO2; Test Result: 100 % |
| V_ADMINBY: | OTH |
| OTHER_MEDS: | |
| CUR_ILL: | |
| HISTORY: | |
| PRIOR_VAX: | |
| SPLTTYPE: | FRPFIZER INC202200293918 |
| FORM_VERS: | 2 |
| TODAYS_DATE: | 01 March 2022 |
| BIRTH_DEFECT: | |
| OFC_VISIT: | |
| ER_ED_VISIT: | |
| ALLERGIES: | |
| V_FUNDBY: | |
Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.
AND PLEASE read the FAQ first.
OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.